Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
solution for injection in pre-filled syringe
DRUG
3 trials
Sponsors
Sanofi-Aventis Recherche & Developpement
, Curateq Biologics Private Limited
, Hanmi Pharm. Co. Ltd.
Conditions
Asthma
Chronic Urticaria
Short Bowel Syndrome-associated Intestinal Failure (SBS-IF)
Phase 2
A Multicenter, Proof-of-concept, Phase 2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HM15912 in Adult Subjects with Short Bowel Syndrome-associated Intestinal Failure (SBS-IF) (DOLPHINS-2)
Recruiting
CTIS2024-515160-32-00
Hanmi Pharm. Co. Ltd.
Short Bowel Syndrome-associated Intestinal Failure (SBS-IF)
Start: 2022-02-02
Target: 13
Updated: 2026-01-06
Phase 3
A Phase 3, Randomized, Double-Blind, Parallel Group, Multicentre Study to Compare Efficacy, Safety, Pharmacodynamics, Pharmacokinetics, immunogenicity, of BP11 versus EU-Approved Xolair in patients With Chronic Spontaneous Urticaria Who Are Resistant to H1 Antagonist.
Recruiting
CTIS2024-514764-72-00
Curateq Biologics Private Limited
Chronic Urticaria
Start: 2023-09-27
Target: 474
Updated: 2025-11-26
Phase 4
A randomized, double-blind, placebo controlled study assessing the long-term effect of dupilumab on prevention of lung function decline in patients with uncontrolled moderate to severe asthma (ATLAS)
Recruiting
CTIS2024-513423-16-00
Sanofi-Aventis Recherche & Developpement
Asthma
Start: 2022-08-25
Target: 506
Updated: 2025-10-07